HNSPF
Price
$4.97
Change
-$0.03 (-0.60%)
Updated
Dec 15 closing price
Capitalization
28.51B
Intraday BUY SELL Signals
IXHL
Price
$0.40
Change
-$0.01 (-2.44%)
Updated
Dec 26 closing price
Capitalization
138.07M
Intraday BUY SELL Signals
Interact to see
Advertisement

HNSPF vs IXHL

Header iconHNSPF vs IXHL Comparison
Open Charts HNSPF vs IXHLBanner chart's image
Hansoh Pharmaceutical Group
Price$4.97
Change-$0.03 (-0.60%)
Volume$927
Capitalization28.51B
Incannex Healthcare
Price$0.40
Change-$0.01 (-2.44%)
Volume$7.56M
Capitalization138.07M
HNSPF vs IXHL Comparison Chart in %
HNSPF
Daily Signal:
Gain/Loss:
IXHL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HNSPF vs. IXHL commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSPF is a Hold and IXHL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (HNSPF: $4.97 vs. IXHL: $0.40)
Brand notoriety: HNSPF and IXHL are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HNSPF: 354% vs. IXHL: 34%
Market capitalization -- HNSPF: $28.51B vs. IXHL: $138.07M
HNSPF [@Pharmaceuticals: Generic] is valued at $28.51B. IXHL’s [@Pharmaceuticals: Generic] market capitalization is $138.07M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSPF’s FA Score shows that 2 FA rating(s) are green whileIXHL’s FA Score has 0 green FA rating(s).

  • HNSPF’s FA Score: 2 green, 3 red.
  • IXHL’s FA Score: 0 green, 5 red.
According to our system of comparison, HNSPF is a better buy in the long-term than IXHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HNSPF’s TA Score shows that 2 TA indicator(s) are bullish while IXHL’s TA Score has 3 bullish TA indicator(s).

  • HNSPF’s TA Score: 2 bullish, 2 bearish.
  • IXHL’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, HNSPF is a better buy in the short-term than IXHL.

Price Growth

HNSPF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while IXHL (@Pharmaceuticals: Generic) price change was -8.93% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.01%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +23.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.01% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($28.5B) has a higher market cap than IXHL($138M). HNSPF YTD gains are higher at: 133.218 vs. IXHL (-81.189).
HNSPFIXHLHNSPF / IXHL
Capitalization28.5B138M20,652%
EBITDAN/A-47.3M-
Gain YTD133.218-81.189-164%
P/E Ratio43.71N/A-
RevenueN/A12K-
Total CashN/A73.3M-
Total DebtN/A210K-
TECHNICAL ANALYSIS
Technical Analysis
HNSPFIXHL
RSI
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
25%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
29%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
13%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 5 days ago
37%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HNSPF
Daily Signal:
Gain/Loss:
IXHL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
YCS50.730.38
+0.76%
ProShares UltraShort Yen
LRGG29.890.09
+0.30%
Nomura Focused Large Growth ETF
OVL54.08-0.03
-0.05%
Overlay Shares Large Cap Equity ETF
VBK308.75-1.13
-0.36%
Vanguard Small-Cap Growth ETF
QQQJ37.50-0.14
-0.37%
Invesco NASDAQ Next Gen 100 ETF

HNSPF and

Correlation & Price change

A.I.dvisor tells us that HNSPF and RMTI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNSPF and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
RMTI - HNSPF
24%
Poorly correlated
+6.83%
AYURF - HNSPF
11%
Poorly correlated
N/A
AKAN - HNSPF
8%
Poorly correlated
-10.31%
IXHL - HNSPF
5%
Poorly correlated
-2.87%
BFRI - HNSPF
4%
Poorly correlated
+0.17%
More

IXHL and

Correlation & Price change

A.I.dvisor tells us that IXHL and INM have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IXHL and INM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IXHL
1D Price
Change %
IXHL100%
-2.87%
INM - IXHL
33%
Poorly correlated
-0.81%
ESPR - IXHL
23%
Poorly correlated
+2.28%
NBIX - IXHL
22%
Poorly correlated
-1.14%
HROW - IXHL
22%
Poorly correlated
-0.14%
YCBD - IXHL
20%
Poorly correlated
+5.66%
More